Pangenomic Health Inc. (NARA:CSE) closed at $0.170 on October 23, 2026, up 6.25% on the day. The stock trades 86.2% below its 52-week high of $1.23 and 6.3% above its 52-week low of $0.160. Over the past year, it lost 84.4%. Pangenomic Health Inc. is part of the Life Sciences sector.
In 252 trading sessions since October 23, 2025, NARA closed higher on 47 days (19%). Its best day was March 31, 2026 (+56.67%) and its worst was October 9, 2026 (-36.00%). The stock moved 10% or more in a single session 57 times. It opened at least 5% above the previous day's high 21 times.
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's unique user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The company's digital therapeutics clinic platform, the PlantGx Platform, provides health practitioners with access to a consumer's Nara App data in order to assist them to optimize the identification of appropriate natural remedies and monitor a patient's prognosis during treatment.
Find more stocks like NARA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.